MyBody-X angle on APOE Männer

The MyBody-X DNA test can detect APOE variants (ε2, ε3, ε4), which are associated with Alzheimer's and cardiovascular risk. For men, research indicates that ε4 carriers have an increased risk of late-onset Alzheimer's, with some studies suggesting earlier cognitive decline in men compared to women – but the evidence is mixed. Crucially, APOE ε4 is a risk factor, not a diagnosis. Effect sizes are modest; many ε4 carriers never develop the disease, and non-carriers can still be affected. The test is meant for awareness, not prediction. Lifestyle factors (Mediterranean diet, exercise, sleep, blood pressure control) have a greater impact than genetics alone. Caveat: This is not a medical device; consult a doctor if there is a family history. Evidence is based on GWAS and observational studies, not randomized trials. MyBody-X emphasizes education, not fear-mongering.